[HTML][HTML] Ferroptosis in Parkinson's disease: glia–neuron crosstalk

ZL Wang, L Yuan, W Li, JY Li - Trends in molecular medicine, 2022 - cell.com
Parkinson's disease (PD) is characterized by dopaminergic (DA) neuron loss and the
formation of cytoplasmic protein inclusions. Although the exact pathogenesis of PD is …

Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination

M Zirngibl, P Assinck, A Sizov, AV Caprariello… - Molecular …, 2022 - Springer
Background The dietary consumption of cuprizone–a copper chelator–has long been known
to induce demyelination of specific brain structures and is widely used as model of multiple …

[HTML][HTML] 13 reasons why the brain is susceptible to oxidative stress

JN Cobley, ML Fiorello, DM Bailey - Redox biology, 2018 - Elsevier
The human brain consumes 20% of the total basal oxygen (O 2) budget to support ATP
intensive neuronal activity. Without sufficient O 2 to support ATP demands, neuronal activity …

Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells

D Belov Kirdajova, J Kriska, J Tureckova… - Frontiers in cellular …, 2020 - frontiersin.org
A plethora of neurological disorders shares a final common deadly pathway known as
excitotoxicity. Among these disorders, ischemic injury is a prominent cause of death and …

The role of iron in brain ageing and neurodegenerative disorders

RJ Ward, FA Zucca, JH Duyn, RR Crichton… - The Lancet …, 2014 - thelancet.com
In the CNS, iron in several proteins is involved in many important processes such as oxygen
transportation, oxidative phosphorylation, myelin production, and the synthesis and …

[HTML][HTML] Biomarkers of Nutrition for Development (BOND)—iron review

S Lynch, CM Pfeiffer, MK Georgieff, G Brittenham… - The Journal of …, 2018 - Elsevier
This is the fifth in the series of reviews developed as part of the Biomarkers of Nutrition for
Development (BOND) program. The BOND Iron Expert Panel (I-EP) reviewed the extant …

Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics

AA Belaidi, AI Bush - Journal of neurochemistry, 2016 - Wiley Online Library
Brain iron homeostasis is increasingly recognized as a potential target for the development
of drug therapies for aging‐related disorders. Dysregulation of iron metabolism associated …

Docosahexaenoic acid and cognition throughout the lifespan

MJ Weiser, CM Butt, MH Mohajeri - Nutrients, 2016 - mdpi.com
Docosahexaenoic acid (DHA) is the predominant omega-3 (n-3) polyunsaturated fatty acid
(PUFA) found in the brain and can affect neurological function by modulating signal …

Myelin and iron concentration in the human brain: a quantitative study of MRI contrast

C Stüber, M Morawski, A Schäfer, C Labadie… - Neuroimage, 2014 - Elsevier
During the last five years ultra-high-field magnetic resonance imaging (MRI) has enabled an
unprecedented view of living human brain. Brain tissue contrast in most MRI sequences is …

[HTML][HTML] Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study

C Langkammer, F Schweser, N Krebs, A Deistung… - Neuroimage, 2012 - Elsevier
Quantitative susceptibility mapping (QSM) is a novel technique which allows determining the
bulk magnetic susceptibility distribution of tissue in vivo from gradient echo magnetic …